Raised in 2026 · Worldwide
Precision medicine startups that raised in 2026
37 precision medicine startups raised money in 2026 in rounds we track, $2.9B between them this year. Each sits in the segment that says what it does, ranked by what it raised this year.
Funding by segment
- Precision oncology$2.6B18
- Companion diagnostics and biomarkers$249M13
- Data and AI platforms$68M6
Where they are based
- United States22$2.8B
- United Kingdom7$42M
- Canada2$30M
- Switzerland2$5.4M
- India1$9.8M
- Argentina1$8.0M
- Greece1$344K
- Austria1$7.4M
United States
United Kingdom
Canada
Switzerland
India
Argentina
Greece
AustriaFounded
7 without a founding year on record.
Total raised
- Under $1M4
- $1M to $10M17
- $10M to $50M9
- $50M to $250M4
- $250M to $1B2
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
30 of 37 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States22
- United Kingdom7
- Canada2
- Switzerland2
- India1
- Argentina1
- Greece1
- Austria1
Startups by country, 8 countries in all.
Segment by segment
Precision oncology
18 startups · $2.6B raised
BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.0B
ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$633MEnliven TherapeuticsEnliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.United States$460M
OnKure TherapeuticsOnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.United States$150M
Stipple BioStipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022.United States$100M
FORE BiotherapeuticsFore Biotherapeutics is a clinical-stage precision oncology company based in Philadelphia, PA.United States$67M
xCuresxCures is an AI-based precision oncology platform that tightly integrates cancer research and care.United States$46M
Altis LabsAltis Labs, Inc.Canada$25M
Companion diagnostics and biomarkers
13 startups · $249M raised
Alto NeuroscienceAlto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.United States$220M
Axo LongevityAxo Longevity is a high-performance longevity platform based in Europe, founded in 2025.United Kingdom$5.0M
ViewsMLViewsML is a Vancouver-based artificial intelligence company focused on precision medicine and diagnostics through its innovative Canada$4.9M
AcurionAcurion develops AI-driven diagnostic solutions that extract actionable genomic biomarker insights from standard pathology images.United States$4.1M
Alithea GenomicsAlithea Genomics is a biotechnology company founded in May 2020 at the École Polytechnique Fédérale de Lausanne in Switzerland.Switzerland$3.8M
SEQUENTIALSequential is a biotechnology company focused on personal care and health research.United Kingdom$3.5M
Guilford Street LaboratoriesGuilford Street Laboratories (GSL) is a biotechnology company based in London, founded in 2023 as a spin-out from University ColleUnited Kingdom$2.3M
Droplet ScientificDroplet Scientific Portable and wearable analyzers for continuous, real-time biomarker monitoring.United Kingdom$2.0M
Data and AI platforms
6 startups · $68M raised
PacegenixPacegenix is a healthcare tech company advancing cardiovascular care with data-driven precision medicine solutions.United States$23M
PrenosisPrenosis Inc.United States$20M
Beacon BiosignalsBeacon Biosignals is a Boston-based neurotechnology company founded in 2019.United States$11M
AitiologicAitiologic is an Austrian precision medicine startup based in Vienna, founded in June 2023.Austria$7.4M
Sano GeneticsSano Genetics is a biotechnology and software company based in Cambridge, UK, founded in 2017.United Kingdom$3.6M
PGxAIPGxAI is an AI-powered pharmacogenetics platform that redefines precision medicine using proprietary algorithms and real-world data.United States$3.0M
How this map is made. Every startup here has raised money in rounds we track, and raised in 2026. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in precision medicine, and goes to the first segment whose words it carries. Each segment shows its biggest raisers this year first. Rebuilt nightly; updated 15 November 2026.
More market maps
All mapsWho backs precision medicine?
Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.